Fedora Pharmaceuticals Inc. — Form D
Fedora Pharmaceuticals Inc. of EDMONTON, A0, a company, filed a Form D exempt-offering notice with the SEC on 2025-06-06. The offering totals $7.2M, of which $895K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2025-06-06
- Form: D
- Accession: 0001576423-25-000004
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $7.2M
- Amount sold: $895K
- Remaining: $6.3M
- Minimum investment: $70K
- Investors: 10
- Date of first sale: 2025-04-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-548229
Issuer
- Name: Fedora Pharmaceuticals Inc.
- CIK: 0001576423
- Entity type: Corporation
- Jurisdiction: ALBERTA, CANADA
- Incorporated: 2011
- Address: 11629 105 AVENUE NW, EDMONTON, A0, T5H 092
- Phone: (708) 761-0561
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Sarat Maharaj | Director | Edmonton, A0 |
| Christopher Micetich | Director | Edmonton, A0 |
| Leonard Post | Director | Edmonton, A0 |
| Christopher Micetich | Executive Officer | Edmonton, A0 |
| Leonard E Post | Director | Vacaville, CA |
| Ronald Odynsk | Director | Edmonton, A0 |
Other filings by this issuer (1)
More